Patt
Debra Patt, MD, PhD, MBA, is a medical oncologist/hematologist and breast cancer specialist who practices in Austin, Texas, for Texas Oncology. She is the current president of the Community Oncology Alliance, a member of the board of directors for the American Society of Clinical Oncology, and medical director for public policy for The US Oncology Network. As part of a wide-ranging interview, Evidence-Based Oncology (EBO) asked Patt about the US surgeon general’s January 3, 2025, advisory on alcohol and cancer risk.
EBO: What were your thoughts on the surgeon general’s advisory?
Patt: I saw the surgeon general’s report on alcohol and cancer, and that increased alcohol intake is associated with some particular cancers, specifically, head and neck cancer, esophageal cancer, breast cancer, liver cancer, and colorectal cancer.
Alcohol intake is associated with an increased risk of those cancers; in particular, heavy alcohol intake is associated with an increased risk of those cancers. This is important information to get out. We need to be talking to our patients about it and allow them to make educated decisions about how they might modify their lifestyle in order to continue to live cancer free.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Diabetes Risk Driven by Economic Disparity in Hispanic, Latino Communities
March 28th 2025Hispanic and Latino adults found that while preserving cultural identity may initially benefit health, socioeconomic factors like education level significantly impact diabetes and hypertension rates, highlighting the need for targeted health interventions across diverse subgroups.
Read More